Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis

Table 1

Main characteristics of all studies included in the meta-analysis for AR.

References	Year	Origin	Case-controls	Antibody source	Dilution	Cut-off value
Rakha et al. [1]	2007	UK	277/1370	BioGenex	1 : 30	>0%
Pristauz et al. [8]	2010	Austria	44/91	Dako	1 : 100	Not available
Gasparini et al. [10]	2014	USA	371/256	Dako	1 : 100	>5%
Chae et al. [22]	2011	Korea	12/157	Dako	Not available	>10
Hu et al. [23]	2011	USA	211/1256	Dako	1 : 200	>1%
Koo and Jung [24]	2011	Korea	8/109	Lab Vision Corp	1 : 100	Not available
Luo et al. [25]	2010	China	137/132	Zymed	1 : 100	>1%
Loibl et al. [26]	2011	Germany	111/562	Dako	1 : 150	>1%
Micello et al. [27]	2010	Italy	138/88	Novocastra	1 : 20	>10%
Niemeier et al. [28]	2010	USA	30/159	Dako	1 : 50	>10%
Ogawa et al. [29]	2008	Japan	42/185	Dako	1 : 100	>10%
Park et al. [30]	2009	Korea	63/350	Dako	Not available	>10%
Park et al. [31]	2011	Korea	156/775	Thermo Scientific	Not available	>10%
Peters et al. [32]	2012	Australia	18/36	Not available	Not available	Not available